REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 201 filers reported holding REATA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $620 | -77.8% | 6,819 | -90.7% | 0.00% | -71.4% |
| Q4 2022 | $2,787 | -99.7% | 73,374 | +97.1% | 0.01% | +133.3% |
| Q3 2022 | $935,000 | -76.3% | 37,218 | -4.9% | 0.00% | -62.5% |
| Q3 2021 | $3,937,000 | -29.1% | 39,135 | -0.2% | 0.01% | -27.3% |
| Q2 2021 | $5,549,000 | +8.2% | 39,210 | -23.7% | 0.01% | 0.0% |
| Q1 2021 | $5,127,000 | -22.6% | 51,421 | -4.1% | 0.01% | -26.7% |
| Q4 2020 | $6,627,000 | +393.4% | 53,613 | +288.8% | 0.02% | +275.0% |
| Q3 2020 | $1,343,000 | -41.1% | 13,789 | -5.6% | 0.00% | -42.9% |
| Q2 2020 | $2,279,000 | +8.1% | 14,607 | 0.0% | 0.01% | -12.5% |
| Q1 2020 | $2,108,000 | – | 14,607 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |